Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
World-First NHS Test To Curb Transfusion Side-effects For Thousands with Inherited Blood Disorders
The NHS is set to introduce a new genetic blood matching test for thousands living […]
NHS Rolls Out New ‘Lifeline’ Combination Therapy for Hundreds of Women With Womb Cancer
Hundreds of women with advanced womb cancer in England are to be offered a new […]
NHS Progress On Waiting List Despite Busiest Winter On Record
The NHS has continued to progress against its elective recovery plan with the number of […]
Life-Saving NHS Test Helping To Diagnose Thousands With Cancer-Causing Syndrome
A life-saving NHS testing programme is helping to diagnose thousands of people with a genetic […]
NHS Hits Milestone of 200 Children with Hepatitis C Treated in Bid to Stamp Out Virus
Two hundred children in England have now received life-saving treatment for hepatitis C as part […]
First New Life-extending NHS Treatment for Incurable Cervical Cancer in Almost 15 Years
A life-extending treatment for advanced cervical cancer will be made available to hundreds of NHS […]
NHS Slashes Longest Elective and Cancer Patient Waiting Lists
The number of people waiting over 18 months for NHS care has fallen again despite […]
NHS Patients with Rare Genetic Disorders to be Fast-tracked to Earlier Diagnosis and Specialist Care
Hundreds of people with a range of rare conditions primarily affecting the central nervous system […]
Government Plans to Bolster Patient Safety and Boost Support for Frontline Staff by Streamlining the System for Healthcare Regulators
The government has reaffirmed its commitment to streamline the system, improve patient safety and expand […]
First Baby Receives Life-Saving Gene Therapy on NHS
A 19-month-old baby girl called Teddi has become the first child in the UK to […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more